Healthcare entity
Pascal Soriot is most often covered alongside AstraZeneca, which appears in 2 of these 2 stories. Their average consequence score of 9 runs above the beat's 5.6 for that window. Source depth averages 3 original sources per story, versus 2 across the same-window beat baseline.
Last mentioned: Aug 3, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Pascal Soriot is most often covered alongside AstraZeneca, which appears in 2 of these 2 stories. Their average consequence score of 9 runs above the beat's 5.6 for that window. Source depth averages 3 original sources per story, versus 2 across the same-window beat baseline. The clearest coverage concentration is acquisition: 1 of 2 stories, with the rest divided among 1 other category. Pascal Soriot appears in 2 tracked Healthcare stories published from August 2, 2026 through August 3, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 26 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Pascal Soriot. Shared-story counts are live from our verified record — not editorial picks.
The potential combination of two pharmaceutical powerhouses would concentrate ownership of critical cardiovascular and oncology treatments, raising concerns about pricing power, NHS supply chains, and worldwide health equity.
A potential $400 billion merger between AstraZeneca and Bristol Myers Squibb could reshape oncology competition, with implications for drug costs, patient access, and payer negotiations. The combined portfolio would dominate key cancer markets.
Pascal Soriot is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
